Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
Do you hold mTOR inhibitors during radiation?
If so, how long pre- and post-RT?
Answer from: Radiation Oncologist at Community Practice
MTOR inhibitors may be radiosensitizers but in limited times, I have not held this drug for palliative RT.
Comments
Radiation Oncologist at Torrance Memorial Medical Center
Thanks @Sushil Beriwal! Do you hold for longer cou...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
I would base on the clinical risk of holding vs. c...
8125
8126
Sign in or Register to read more
16023
Related Questions
For a cutaneous malignancy near the eyelid, how do you decide whether to use an internal eye shield or an external eye shield during treatment?
Would you favor radiation or immune modulating treatment like imiquimod to treat an uncomplicated basal cell carcinoma on the nose in an elderly patient for whom you'd like to avoid surgery?
How would you approach management of a large, fungating squamous cell carcinoma of the auricle if surgical management is not desired by the patient?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
How would you manage a scalp squamous cell carcinoma s/p Mohs with high risk features who underwent placental grafting to expedite the healing process?
How would you manage a large area of multiple, recurrent cutaneous squamous cell carcinomas of the scalp with ulcerations and non-healing areas despite cryotherapy, multiple Mohs procedures, and 5-FU?
How would you manage BCC to the left cheek after only half of a radiation course was completed three months ago and non-operative management is preferred?
How would you treat locally advanced melanoma of the scalp with several in transit lesions and a metastatic lesion to the parotid if the patient is progressing on immunotherapy such as pembrolizumab?
When do you recommend SRT, if ever, for small SCCs and BCCs?
Would you consider adjuvant immunotherapy for a patient with high-risk (N3 nodes) Merkel cell carcinoma following definitive surgical resection and adjuvant radiation therapy?
Thanks @Sushil Beriwal! Do you hold for longer cou...
I would base on the clinical risk of holding vs. c...